Bioinformatic Exploration for Prognostic Significance of Sphingolipid Metabolism-Related Genes in Invasive Ductal Carcinoma Using the Cancer Genome Atlas Cohort

References

• DeSantis CE, Ma J, Goding Sauer A, Newman LA, Jemal A. Breast cancer statistics, 2017, racial disparity in mortality by state. CA Cancer J Clin. 2017;67(6):439–448. doi:10.3322/caac.21412
   PubMed Web of Science ®Google Scholar
• Makki J. Diversity of Breast Carcinoma: histological Subtypes and Clinical Relevance. Clin Med Insights Pathol. 2015;8:23–31. doi:10.4137/CPath.S31563
   PubMed Web of Science ®Google Scholar
• Sharma GN, Dave R, Sanadya J, Sharma P, Sharma KK. Various types and management of breast cancer: an overview. J Adv Pharm Technol Res. 2010;1(2):109–126.
   PubMedGoogle Scholar
• Bundred NJ. Prognostic and predictive factors in breast cancer. Cancer Treat Rev. 2001;27(3):137–142. doi:10.1053/ctrv.2000.0207
   PubMed Web of Science ®Google Scholar
• Prat A, Pineda E, Adamo B, et al. Clinical implications of the intrinsic molecular subtypes of breast cancer. Breast. 2015;24(Suppl 2):S26–35. doi:10.1016/j.breast.2015.07.008
   PubMed Web of Science ®Google Scholar
• Wang Z, Jensen MA, Zenklusen JC. A Practical Guide to The Cancer Genome Atlas (TCGA). Methods Mol Biol. 2016;1418:111–141. doi:10.1007/978-1-4939-3578-9_6
   PubMedGoogle Scholar
• Pralhada Rao R, Vaidyanathan N, Rengasamy M, Mammen Oommen A, Somaiya N, Jagannath MR. Sphingolipid metabolic pathway: an overview of major roles played in human diseases. J Lipids. 2013;2013:178910. doi:10.1155/2013/178910
   PubMedGoogle Scholar
• Hannun YA, Obeid LM. Principles of bioactive lipid signalling: lessons from sphingolipids. Nat Rev Mol Cell Biol. 2008;9(2):139–150. doi:10.1038/nrm2329
   PubMed Web of Science ®Google Scholar
• Erez-Roman R, Pienik R, Futerman AH. Increased ceramide synthase 2 and 6 mRNA levels in breast cancer tissues and correlation with sphingosine kinase expression. Biochem Biophys Res Commun. 2010;391(1):219–223. doi:10.1016/j.bbrc.2009.11.035
   PubMed Web of Science ®Google Scholar
• Hartmann D, Lucks J, Fuchs S, et al. Long chain ceramides and very long chain ceramides have opposite effects on human breast and colon cancer cell growth. Int J Biochem Cell Biol. 2012;44(4):620–628. doi:10.1016/j.biocel.2011.12.019
   PubMed Web of Science ®Google Scholar
• Geffken K, Spiegel S. Sphingosine kinase 1 in breast cancer. Adv Biol Regul. 2018;67:59–65. doi:10.1016/j.jbior.2017.10.005
   PubMedGoogle Scholar
• Acharya S, Yao J, Li P, et al. Sphingosine Kinase 1 Signaling Promotes Metastasis of Triple-Negative Breast Cancer. Cancer Res. 2019;79(16):4211–4226. doi:10.1158/0008-5472.CAN-18-3803
   PubMed Web of Science ®Google Scholar
• Kochel TJ, Goloubeva OG, Fulton AM. Upregulation of Cyclooxygenase-2/Prostaglandin E2 (COX-2/PGE2) Pathway Member Multiple Drug Resistance-Associated Protein 4 (MRP4) and Downregulation of Prostaglandin Transporter (PGT) and 15-Prostaglandin Dehydrogenase (15-PGDH) in Triple-Negative Breast Cancer. Breast Cancer (Auckl). 2016;10:61–70. doi:10.4137/BCBCR.S38529
   PubMedGoogle Scholar
• Ruckhaberle E, Rody A, Engels K, et al. Microarray analysis of altered sphingolipid metabolism reveals prognostic significance of sphingosine kinase 1 in breast cancer. Breast Cancer Res Treat. 2008;112(1):41–52. doi:10.1007/s10549-007-9836-9
   PubMed Web of Science ®Google Scholar
• de Hoon MJ, Imoto S, Nolan J, Miyano S. Open source clustering software. Bioinformatics. 2004;20(9):1453–1454. doi:10.1093/bioinformatics/bth078
   PubMed Web of Science ®Google Scholar
• Evans C, Hardin J, Stoebel DM. Selecting between-sample RNA-Seq normalization methods from the perspective of their assumptions. Brief Bioinform. 2018;19(5):776–792. doi:10.1093/bib/bbx008
   PubMed Web of Science ®Google Scholar
• Ogretmen B. Sphingolipid metabolism in cancer signalling and therapy. Nat Rev Cancer. 2018;18(1):33–50. doi:10.1038/nrc.2017.96
   PubMed Web of Science ®Google Scholar
• Friedman AA, Letai A, Fisher DE, Flaherty KT. Precision medicine for cancer with next-generation functional diagnostics. Nat Rev Cancer. 2015;15(12):747–756. doi:10.1038/nrc4015
   PubMed Web of Science ®Google Scholar
• Arnedos M, Vicier C, Loi S, et al. Precision medicine for metastatic breast cancer–limitations and solutions. Nat Rev Clin Oncol. 2015;12(12):693–704. doi:10.1038/nrclinonc.2015.123
   PubMed Web of Science ®Google Scholar
• Ahmadpour S, Noaparast Z, Abedi SM, Hosseinimehr SJ. (99m)Tc-(tricine)-HYNIC-Lys-FROP Peptide for Breast Tumor Targeting. Anticancer Agents Med Chem. 2018;18(9):1295–1302. doi:10.2174/1871520618666180307142027
   PubMed Web of Science ®Google Scholar
• Ahmadpour S, Noaparast Z, Abedi SM, Hosseinimehr SJ. (99m)Tc-HYNIC-(tricine/EDDA)-FROP peptide for MCF-7 breast tumor targeting and imaging. J Biomed Sci. 2018;25(1):17. doi:10.1186/s12929-018-0420-x
   PubMed Web of Science ®Google Scholar
• Ahmadpour S, Hosseinimehr SJ. Recent developments in peptide-based SPECT radiopharmaceuticals for breast tumor targeting. Life Sci. 2019;239:116870. doi:10.1016/j.lfs.2019.116870
   PubMed Web of Science ®Google Scholar
• Heinz LX, Baumann CL, Koberlin MS, et al. The Lipid-Modifying Enzyme SMPDL3B Negatively Regulates Innate Immunity. Cell Rep. 2015;11(12):1919–1928. doi:10.1016/j.celrep.2015.05.006
   PubMed Web of Science ®Google Scholar
• Yoo TH, Pedigo CE, Guzman J, et al. Sphingomyelinase-like phosphodiesterase 3b expression levels determine podocyte injury phenotypes in glomerular disease. J Am Soc Nephrol. 2015;26(1):133–147. doi:10.1681/ASN.2013111213
   PubMed Web of Science ®Google Scholar
• Mallela SK, Mitrofanova A, Merscher S, Fornoni A. Regulation of the amount of ceramide-1-phosphate synthesized in differentiated human podocytes. Biochim Biophys Acta Mol Cell Biol Lipids. 2019;1864(12):158517. doi:10.1016/j.bbalip.2019.158517
   PubMed Web of Science ®Google Scholar
• Hait NC, Maiti A. The Role of Sphingosine-1-Phosphate and Ceramide-1-Phosphate in Inflammation and Cancer. Mediators Inflamm. 2017;2017:4806541. doi:10.1155/2017/4806541
   PubMed Web of Science ®Google Scholar
• Waldbillig F, Nitschke K, Abdelhadi A, et al. Phosphodiesterase SMPDL3B Gene Expression as Independent Outcome Prediction Marker in Localized Prostate Cancer. Int J Mol Sci. 2020;21(12):4373. doi:10.3390/ijms21124373
   PubMed Web of Science ®Google Scholar
• Yang D, Yang W, Zhang Q, Hu Y, Bao L, Damirin A. Migration of gastric cancer cells in response to lysophosphatidic acid is mediated by LPA receptor 2. Oncol Lett. 2013;5(3):1048–1052. doi:10.3892/ol.2013.1107
   PubMed Web of Science ®Google Scholar
• Onallah H, Davidson B, Reich R. Diverse Effects of Lysophosphatidic Acid Receptors on Ovarian Cancer Signaling Pathways. J Oncol. 2019;2019:7547469. doi:10.1155/2019/7547469
   PubMed Web of Science ®Google Scholar
• Lehtinen L, Vainio P, Wikman H, et al. 15-Hydroxyprostaglandin dehydrogenase associates with poor prognosis in breast cancer, induces epithelial-mesenchymal transition, and promotes cell migration in cultured breast cancer cells. J Pathol. 2012;226(4):674–686. doi:10.1002/path.3956
   PubMed Web of Science ®Google Scholar
• Jang SW, Park WJ, Min H, et al. Altered mRNA expression levels of the major components of sphingolipid metabolism, ceramide synthases and their clinical implication in colorectal cancer. Oncol Rep. 2018;40(6):3489–3500. doi:10.3892/or.2018.6712
   PubMed Web of Science ®Google Scholar